Nutritional status, anthropometrical measurements, socio-economic status, and physical activity in Brazilian university students.

Autor: Bion FM (AUTHOR), Chagas MH (AUTHOR), Muniz Gde S (AUTHOR), de Sousa LG (AUTHOR)

Publikováno v: Nutrición Hospitalaria. may/jun2008, Vol. 23 Issue 3, p234-241. 8p.

Probiotics enhance alveolar bone microarchitecture, intestinal morphology and estradiol levels in osteoporotic animals.

Autor: Lucateli RL; Department of Oral and Maxillofacial Surgery and Periodontology, School of Dentistry of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil., Silva PHF; Department of Oral and Maxillofacial Surgery and Periodontology, School of Dentistry of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil., Salvador SL; Department of Clinical Analyses, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil., Ervolino E; Division of Histology, Department of Basic Sciences, Dental School of Araçatuba, UNESP, Araçatuba, São Paulo, Brazil., Furlaneto FAC; Department of Oral and Maxillofacial Surgery and Periodontology, School of Dentistry of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil., Marciano MA; Department of Restorative Dentistry, School of Dentistry of Piracicaba, University of Campinas, Piracicaba, São Paulo, Brazil., Antunes TBM; Department of Restorative Dentistry, School of Dentistry of Piracicaba, University of Campinas, Piracicaba, São Paulo, Brazil., Del Arco MCG; Department of Clinical Analyses, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil., Tardelli MDC; Department of Oral and Maxillofacial Surgery and Periodontology, School of Dentistry of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil., de Sousa LG; Department of Morphology, Stomatology, and Physiology, School of Dentistry of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Messora MR; Department of Oral and Maxillofacial Surgery and Periodontology, School of Dentistry of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil.

Publikováno v: Journal of periodontal research [J Periodontal Res] 2024 Aug; Vol. 59 (4), pp. 758-770. Date of Electronic Publication: 2024 May 03.

Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study.

Autor: de Sousa LG; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu S; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bhosale P; Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Altan M; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Darbonne W; Roche/Genentech, South San Francisco, CA, USA., Schulze K; Roche/Genentech, South San Francisco, CA, USA., Dervin S; Roche/Genentech, South San Francisco, CA, USA., Yun C; Roche/Genentech, South San Francisco, CA, USA., Mahvash A; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Verma A; Department of Pathology, Yale-New Haven Hospital, New Haven, CT, USA., Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gite S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cuentas EP; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cho WC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wistuba I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yao JC; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Woodman SE; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Halperin DM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: dmhalperin@mdanderson.org., Ferrarotto R; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: rferrarotto@mdanderson.org.

Publikováno v: Oral oncology [Oral Oncol] 2024 Apr; Vol. 151, pp. 106747. Date of Electronic Publication: 2024 Mar 08.

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.

Autor: Heeke S; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gay CM; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Estecio MR; Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tran H; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morris BB; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang B; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tang X; Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Raso MG; Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rocha P; Medical Oncology Department, Hospital del Mar, Barcelona, Spain., Lai S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UTHealth Houston, Houston, TX, USA., Arriola E; Medical Oncology Department, Hospital del Mar, Barcelona, Spain., Hofman P; Laboratory of Clinical and Experimental Pathology, IHU RespirERA, Nice Hospital, University Côte d'Azur, Nice, France., Hofman V; Laboratory of Clinical and Experimental Pathology, IHU RespirERA, Nice Hospital, University Côte d'Azur, Nice, France., Kopparapu P; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Lovly CM; Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Concannon K; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., De Sousa LG; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lewis WE; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kondo K; Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hu X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tanimoto A; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vokes NI; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nilsson MB; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stewart A; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jansen M; Pulmonary Department, Ziekenhuisgroep Twente, Hengelo, the Netherlands., Horváth I; National Korányi Institute of Pulmonology, Budapest, Hungary., Gaga M; 7th Respiratory Medicine Department, Athens Chest Hospital, Athens, Greece., Panagoulias V; 2nd Respiratory Medicine Department, Athens Chest Hospital, Athens, Greece., Raviv Y; Department of Medicine, Pulmonology, Institute, Soroka Medical Center, Ben-Gurion University, Beer-Sheva, Israel., Frumkin D; Nucleix Ltd. Rehovot, Israel., Wasserstrom A; Nucleix Ltd. Rehovot, Israel., Shuali A; Nucleix Ltd. Rehovot, Israel., Schnabel CA; Nucleix Inc, San Diego, CA, USA., Xi Y; Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Diao L; Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang Q; Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang J; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Van Loo P; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The Francis Crick Institute, London, UK., Wang J; Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wistuba II; Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Byers LA; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: lbyers@mdanderson.org., Heymach JV; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: jheymach@mdanderson.org.

Publikováno v: Cancer cell [Cancer Cell] 2024 Feb 12; Vol. 42 (2), pp. 225-237.e5. Date of Electronic Publication: 2024 Jan 25.

Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma.

Autor: de Sousa LG; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lazar Neto F; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dal Lago EA; Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sikora A; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hanna E; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moreno A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Glisson BS; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bell D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ferrarotto R; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: rferrarotto@mdanderson.org.

Publikováno v: Oral oncology [Oral Oncol] 2023 Mar; Vol. 138, pp. 106311. Date of Electronic Publication: 2023 Jan 24.